Nothing screams “clinical-fatal” now. The catches I’d specifically tell Claude to look for are mostly **schema/rendering traps**, not lithium content. The JSON wiring itself looks clean from my parse: unique IDs, `correct` IDs match options/tokens, and bow-tie rationale `refId`s line up. 

Watchlist:

1. **Top-level `case_study` may be missing `ngnSkill`.**
   The bowtie has `"ngnSkill": "take_action"`, but the parent case-study item does not. If schema 1.5 still requires common question fields on every top-level item, this is a validator fail. If case-study parents are exempt, fine.

2. **Parent `case_study` rationale has no `byChoice`.**
   Again, this may be allowed for case-study wrappers, but if the validator expects `rationale.byChoice` on every top-level question, it will fail. Embedded questions all have `byChoice`.

3. **All embedded questions have empty `glossary: []`.**
   This might validate, but it violates the usual bank-generation style where each displayed item gets 2–5 glossary terms. Not a clinical blocker, but if Claude is promoting for learner quality, this is worth filling or intentionally waiving.

4. **Bowtie may be too standalone-light on aspiration.**
   The bowtie stem includes obtundation but does **not** mention the earlier vomiting. The action “Maintain aspiration precautions” is still defensible from obtundation alone, but its rationale says “obtunded with active vomiting.” Either add “recent active vomiting” to the bowtie stem or soften the rationale to “obtunded with recent vomiting/aspiration risk.”

5. **Category drift on embedded q2.**
   q2 is categorized as `Management of Care`, but it is really airway/aspiration priority. `Physiological Adaptation` or `Reduction of Risk Potential` may be cleaner. Not a promotion blocker unless your coverage accounting cares.

6. **Bowtie duplicate exposure risk.**
   If the app treats the bowtie as a separate top-level item, the learner may encounter it apart from the case study. That is okay only if the bowtie stem is self-sufficient. I’d make the stem slightly fuller: HCTZ, poor intake/vomiting/diarrhea, obtundation, myoclonus/fasciculations, lithium 2.6, impaired renal clearance, minimal response to fluids.

7. **Minor wording: “definitive treatment” for dialysis.**
   In the bowtie rationale, “Dialysis is the definitive treatment…” is acceptable for this severe neurotoxic case, but I’d slightly soften to “the urgent extracorporeal treatment” or “the indicated escalation” so it does not imply every lithium toxicity case needs dialysis.

Clinical content otherwise looks sound: thiazide-lithium mechanism, airway priority, dialysis escalation, KCl clarification, rebound monitoring, and psychosocial scope are all aligned.
